An Analytical Reference Standard
Related Products
Alternative(s)
21449Retigabine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Retigabine (hydrochloride)

Item No. 39309

Synonyms
Synonyms
  • D 20443
  • Ezogabine
  • GKE 841
  • GW 582892X
  • WAY-143841
Technical Information
Formal Name
N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamic acid, ethyl ester, dihydrochloride
CAS Number
150812-13-8
Molecular Formula
C16H18FN3O2 • 2HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 10 mg/mlDMSO: 20 mg/mlEthanol: Slightly solublePBS (pH 7.2): 10 mg/ml
λmax
259 nm
SMILES
O=C(OCC)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1.Cl.Cl
InChi Code
InChI=1S/C16H18FN3O2.2ClH/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11;;/h3-9,19H,2,10,18H2,1H3,(H,20,21);2*1H
InChi Key
WSGFOWNASITQHJ-UHFFFAOYSA-N
Regulatory Information
DEA Schedule
V
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    Retigabine (Item No. 39309) is an analytical reference standard categorized as a positive allosteric modulator (PAM) of KCNQ2-5 (Kv7.2-7.5) potassium ion channels.1 Formulations containing retigabine have been used in the treatment of partial epilepsies. Retigabine is regulated as a Schedule V compound in the United States. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Gunthrope, M.J., Large, C.H., and Sankar, R. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy. Epilepsia 53(3), 412-424 (2012).